Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus experienced complete hair regrowth after treatment with thalidomide.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Fever and rash can be early signs of lupus.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

The document summarized various dermatology studies and case reports.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.